1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
Real-time Euronext Amsterdam  -  11:36 2022-08-12 am EDT
19.43 EUR   -0.58%
08/12Vascular experts establish Appropriate Use of Intravascular Ultrasound (IVUS) in peripheral interventions
GL
08/12Vascular experts establish Appropriate Use of Intravascular Ultrasound (IVUS) in peripheral interventions
AQ
07/29Signify sees dimmer profit margins as inflation and supply chains weigh
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philips sees 'very encouraging' results from tests on recalled ventilators

06/28/2022 | 02:37am EDT

AMSTERDAM, June 28 (Reuters) - Dutch health technology company Philips said on Tuesday that it had seen "very encouraging" results from independent tests on the ventilators it recalled last year due to concerns over potential health risks from a type of foam used in the devices.

The tests showed foam degradation almost exclusively in machines that were cleaned with unauthorised ozon-based products, Chief Executive Frans van Houten said.

"What we have seen is that foam degradation is very rare", Van Houten told Reuters in a telephone interview.

"Inspection of over 60,000 machines in the U.S. has shown foam degradation in less than 0.5% of the machines users said had not been cleaned with ozon." (Reporting by Bart Meijer, Editing by Louise Heavens)


© Reuters 2022
All news about PHILIPS NV
08/12Vascular experts establish Appropriate Use of Intravascular Ultrasound (IVUS) in periph..
GL
08/12Vascular experts establish Appropriate Use of Intravascular Ultrasound (IVUS) in periph..
AQ
07/29Signify sees dimmer profit margins as inflation and supply chains weigh
RE
07/27PHILIPS NV : Deutsche Bank sticks Neutral
MD
07/27PHILIPS NV : JP Morgan keeps a Sell rating
MD
07/26European ADRs Move Lower in Tuesday Trading
MT
07/26PHILIPS NV : Jefferies remains Neutral
MD
07/26PHILIPS NV : Deutsche Bank reiterates its Neutral rating
MD
07/26PHILIPS NV : UBS remains a Sell rating
MD
07/26PHILIPS : Q2 2022 webcast transcript
PU
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2022 18 186 M 18 647 M 18 647 M
Net income 2022 575 M 590 M 590 M
Net Debt 2022 4 440 M 4 553 M 4 553 M
P/E ratio 2022 33,4x
Yield 2022 3,73%
Capitalization 17 083 M 17 516 M 17 516 M
EV / Sales 2022 1,18x
EV / Sales 2023 1,09x
Nbr of Employees 78 831
Free-Float 98,4%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 19,43 €
Average target price 24,58 €
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Shez Partovi Chief Medical, Innovation & Strategy Officer
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-40.71%17 516
THERMO FISHER SCIENTIFIC-9.60%232 151
DANAHER CORPORATION-9.50%211 818
INTUITIVE SURGICAL, INC.-33.66%84 285
EDWARDS LIFESCIENCES CORPORATION-19.10%64 424
SIEMENS HEALTHINEERS AG-21.51%60 400